Bank Of New York Mellon Corp Chimerix Inc Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.19 - $2.09 $514,026 - $902,785	431,955 New	431,955 $544 Million
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $768,452 - $1.08 Million	460,151 New	460,151 $855,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $39,939 - $60,902	22,066 Added 8.68%	276,367 $533,000
Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $5,409 - $21,557	-4,037 Reduced 1.56%	254,301 $529,000
Q1 2022 May 11, 2022	SELL	$4.58 - $6.8 $6,805 - $10,104	-1,486 Reduced 0.57%	258,338 $1.18 Million
Q4 2021 Feb 11, 2022	BUY	$5.23 - $7.18 $33,461 - $45,937	6,398 Added 2.52%	259,824 $1.67 Million
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $173,352 - $255,360	29,184 Added 13.01%	253,426 $1.57 Million
Q2 2021 Aug 11, 2021	BUY	$7.54 - $9.79 $121,846 - $158,206	16,160 Added 7.77%	224,242 $1.79 Million
Q1 2021 May 13, 2021	SELL	$4.76 - $11.25 $12,923 - $30,543	-2,715 Reduced 1.29%	208,082 $2.01 Million
Q4 2020 Feb 09, 2021	BUY	$2.43 - $5.42 $50,558 - $112,768	20,806 Added 10.95%	210,797 $1.02 Million
Q3 2020 Nov 12, 2020	SELL	$2.3 - $3.72 $19,340 - $31,281	-8,409 Reduced 4.24%	189,991 $473,000
Q2 2020 Aug 12, 2020	BUY	$1.33 - $3.63 $14,493 - $39,556	10,897 Added 5.81%	198,400 $615,000
Q1 2020 May 06, 2020	BUY	$1.27 - $2.33 $1 - $2	1 Added 0.0%	187,503 $270,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $3,666 - $7,670	2,820 Added 1.53%	187,502 $380,000
Q3 2019 Nov 07, 2019	SELL	$1.93 - $4.21 $53,405 - $116,494	-27,671 Reduced 13.03%	184,682 $434,000
Q2 2019 Aug 12, 2019	BUY	$2.05 - $4.32 $52,877 - $111,430	25,794 Added 13.83%	212,353 $917,000
Q1 2019 May 14, 2019	SELL	$1.79 - $3.12 $18,657 - $32,519	-10,423 Reduced 5.29%	186,559 $392,000
Q4 2018 Feb 11, 2019	SELL	$2.24 - $3.9 $15,160 - $26,395	-6,768 Reduced 3.32%	196,982 $506,000
Q3 2018 Nov 09, 2018	SELL	$3.58 - $4.9 $25,994 - $35,578	-7,261 Reduced 3.44%	203,750 $0
Q2 2018 Aug 06, 2018	SELL	$4.43 - $5.14 $27,089 - $31,431	-6,115 Reduced 2.82%	211,011 $1 Million
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $27,160 - $34,461	5,841 Added 2.76%	217,126 $1.13 Million
Q4 2017 Feb 09, 2018	BUY	$4.32 - $5.52 $912,751 - $1.17 Million	211,285	211,285 $979,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account